<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lipidose™ - Novel Synergistic Therapy for Gram-Negative Infections</title>
    <meta name="description" content="Lipidose™ is a novel therapeutic approach that works synergistically with antibiotics to manage gram-negative bacterial infections by neutralizing endotoxin/LPS and reducing sepsis risk.">
    <link rel="stylesheet" href="styles.css">
    <link rel="icon" type="image/png" href="favicon.png">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.4/css/all.min.css">
</head>
<body>
    <!-- Hero Section with Local Video Background -->
    <section class="hero">
        <div class="video-container">
            <video autoplay muted loop playsinline id="hero-video">
                <source src="assets/Lipidose_Presentation_Video.mp4" type="video/mp4">
                Your browser does not support the video tag.
            </video>
            <div class="overlay"></div>
            <div class="hero-content">
                <h1>Lipidose™</h1>
                <p class="tagline">A Novel Synergistic Approach</p>
                <p class="subtagline">Lipidose™ + Antibiotics - The Future of Gram-Negative Infection Management</p>
            </div>
        </div>
    </section>

    <!-- About Section -->
    <section id="about" class="about">
        <div class="container">
            <h2>About Lipidose™</h2>
            <p>
                Lipidose™ is a groundbreaking therapeutic agent that specifically binds and neutralizes bacterial endotoxin (LPS), 
                which is released during gram-negative bacterial infections. By complementing antibiotic therapy, Lipidose™ 
                significantly reduces inflammation and sepsis risk through its unique dual mechanism of action: enhancing HDL 
                capacity to clear endotoxin and blocking the TLR4 pathway that triggers inflammatory cascades. This synergistic 
                approach addresses both the infection and its toxic consequences simultaneously, providing a comprehensive 
                solution for managing severe gram-negative infections.
            </p>
        </div>
    </section>

    <!-- Fast Facts Section -->
    <section id="facts" class="facts">
        <div class="container">
            <h2>Clinical & Market Value</h2>
            <div class="fact-grid">
                <div class="fact-card">
                    <div class="fact-icon">
                        <i class="fas fa-heartbeat"></i>
                    </div>
                    <h3>Mortality Risk</h3>
                    <p>12-25%</p>
                    <p class="fact-description">in Catheter-Related Bloodstream Infections</p>
                </div>
                <div class="fact-card">
                    <div class="fact-icon">
                        <i class="fas fa-dollar-sign"></i>
                    </div>
                    <h3>Cost Savings</h3>
                    <p>$25,000-$45,000</p>
                    <p class="fact-description">Average savings per patient</p>
                </div>
                <div class="fact-card">
                    <div class="fact-icon">
                        <i class="fas fa-hospital"></i>
                    </div>
                    <h3>Reduced ICU Stay</h3>
                    <p>2-4 Days</p>
                    <p class="fact-description">Shorter intensive care duration</p>
                </div>
                <div class="fact-card">
                    <div class="fact-icon">
                        <i class="fas fa-shield-alt"></i>
                    </div>
                    <h3>Patent Protection</h3>
                    <p>Until 2032+</p>
                    <p class="fact-description">Strategy to extend to 2040+</p>
                </div>
            </div>
        </div>
    </section>

    <!-- Why Lipidose Matters Section -->
    <section id="why" class="why-matters">
        <div class="container">
            <h2>Why Lipidose™ Matters</h2>
            <div class="timeline">
                <div class="timeline-item">
                    <div class="timeline-icon">
                        <i class="fas fa-bacteria"></i>
                    </div>
                    <div class="timeline-content">
                        <h3>The Problem</h3>
                        <p>
                            Gram-negative bacterial infections release massive amounts of lipopolysaccharide (LPS), 
                            triggering dangerous inflammatory cascades that can lead to septic shock and multi-organ failure.
                        </p>
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-icon">
                        <i class="fas fa-capsules"></i>
                    </div>
                    <div class="timeline-content">
                        <h3>Our Solution</h3>
                        <p>
                            Lipidose™ specifically binds and neutralizes LPS before it can escalate into sepsis, 
                            providing critical protection during the vulnerable period of antibiotic treatment.
                        </p>
                    </div>
                </div>
                <div class="timeline-item">
                    <div class="timeline-icon">
                        <i class="fas fa-chart-line"></i>
                    </div>
                    <div class="timeline-content">
                        <h3>The Advantage</h3>
                        <p>
                            Unlike any treatment on the market, Lipidose™ works synergistically with antibiotics, 
                            addressing both the infection and its toxic inflammatory consequences simultaneously.
                        </p>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- Call to Action Section -->
    <section id="cta" class="cta">
        <div class="container">
            <h2>Ready to Learn More?</h2>
            <div class="cta-buttons">
                <button id="request-info" class="btn btn-primary">Request More Info</button>
                <button id="download-pitch-deck" class="btn btn-secondary">Download Pitch Deck</button>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer>
        <div class="container">
            <p>Copyright © <span id="current-year">2023</span> All rights reserved.</p>
            <p>Product name: Lipidose™</p>
            <p>Lipidose™ is a proprietary compound. All rights reserved by its developer.</p>
        </div>
    </footer>

    <script src="script.js"></script>
</body>
</html>
